Related Experiment Video
Updated: May 15, 2025

07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
1.9K
Extracellular vesicles: Roles in oocytes and emerging therapeutic opportunities.
Zhongyu Zhao1, Yinrui Sun2, Renhao Guo1
1Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, China.
Chinese Medical Journal
|April 7, 2025
Summary
Extracellular vesicles (EVs) are crucial for oocyte development and female reproductive health. This review highlights their role in normal function, disease, and potential therapeutic applications for improving oocyte quality.
Area of Science:
- Reproductive Biology
- Cellular and Molecular Biology
- Nanotechnology in Medicine
Background:
- Oocyte quality is essential for successful reproduction and is dependent on complex intercellular communication.
- Extracellular vesicles (EVs), nanoparticles involved in molecular transfer, are increasingly recognized for their role in reproductive processes.
- Understanding EV involvement in oocyte biology is critical for advancing female reproductive health diagnostics and therapeutics.
Purpose of the Study:
- To comprehensively review the influence of extracellular vesicles (EVs) on oocyte development and function.
- To discuss the role of EVs in normal female reproductive physiology and under pathological conditions.
- To summarize the therapeutic potential of EVs in enhancing oocyte quality and managing ovarian diseases.
Main Methods:
- Literature review of studies investigating extracellular vesicles (EVs) and their impact on oocytes.
- Analysis of research on EV cargo composition in both physiological and pathological states.
- Synthesis of findings on the application of therapeutic EVs in reproductive medicine.
Main Results:
- Extracellular vesicles (EVs) are integral to intercellular communication, significantly influencing oocyte maturation and quality.
- EV cargo composition changes under pathological conditions, offering insights into ovarian dysfunction.
- Therapeutic administration of EVs demonstrates potential for improving oocyte quality and treating ovarian diseases.
Conclusions:
- Extracellular vesicles (EVs) are key mediators in maintaining oocyte health and reproductive function.
- EVs represent promising biomarkers for diagnosing reproductive disorders and novel therapeutic agents for fertility treatments.
- Further research into EV biology will unlock new strategies for enhancing female reproductive outcomes.

